Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Phase II/III trial of VLA-43 does not confirm previously seen positive vaccine effect

June 6, 2016

FORGE Life Science announces antiviral compounds

June 6, 2016

Achaogen awarded funding for phase III EPIC study

June 6, 2016

NanoViricides enters partnership to further FluCide-I program

June 3, 2016

GeoVax's Ebola vaccine demonstrates complete protection against EBV challenge

June 2, 2016

Actelion Pharmaceuticals patents antibacterials

June 2, 2016

FDA grants fast track designation for VT-1129

June 2, 2016

FDA approves Teflaro in pediatric patients

June 1, 2016

Soligenix's SGX-943 gets FDA fast track designation

June 1, 2016

EMA committee recommends approval of Epclusa for hepatitis C

May 30, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...